Author:
Tremonti Chris,Celemajer David S.,Marel Christina,Mills Katherine,Foo Shawn,Wilson Jack,Slade Tim,Teesson Maree,Haber Paul
Abstract
Objectives
To prospectively assess rates of QT prolongation, arrhythmia, syncope, and sudden cardiac death (SCD) in a cohort of people with heroin dependence.
Methods
To estimate rates of QT prolongation, arrhythmia, and syncope, a subcohort (n = 130) from the Australian Treatment Outcomes Study, a prospective longitudinal cohort study of 615 people with heroin dependence, underwent medical history, venepuncture, and ECG at the 18- to 20-year follow-up.
To estimate rates of SCD, probabilistic matching for the entire cohort was undertaken with the Australian Institute of Health and Welfare National Death Index. Deaths were classified into suicide, accidental overdose, trauma, unknown, and disease, which were then further subclassified by probability of SCD. SCD rate was the number of possible or probable SCDs divided by total patient years from the cohort.
Results
From the subcohort, 4 participants (3%) met the criteria for QT prolongation; 3 were prescribed methadone. Seven participants (5%) reported history of arrhythmia, including 2 transferred from methadone to buprenorphine. Thirty participants (23%) reported a previous syncopal event—14 diagnosed as nonarrhythmic syncope and 13 not investigated. In the previous 12 months, 66 participants (51%) reported heroin use; 55 participants (42%) were prescribed methadone. No participant had QTc greater than 500 milliseconds.
There were 3 possible SCDs, translating to an estimated SCD rate of 0.29 (CI: 0.05, 0.8) events per 1000 patient years. More cohort members died of overdose (n = 50), suicide (n = 11), and hepatitis C (n = 4).
Conclusions
Low rates of QT prolongation, arrhythmia, syncope, and SCD in the cohort despite high rates of heroin use and methadone treatment.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference33 articles.
1. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence;Cochrane Database Syst Rev,2014
2. Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram;QJM,2007
3. A community-based evaluation of sudden death associated with therapeutic levels of methadone;Am J Med,2008
4. Drug-induced QT prolongation and torsades de pointes pharmacovigilance forum;Pharm Ther,2017
5. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial;Arch Intern Med,2007